Cardiology navigation system maker Stereotaxis plans IPO (initial public offering)
This article was originally published in Clinica
Executive Summary
Stereotaxis, the St Louis, Missouri-based firm that has developed a remote digital control navigation system for cardiovascular procedures in the cath lab, has filed for an initial public offering on Nasdaq. The issue will raise up to $115m, but the company has not yet finalised the terms and timing of the transaction.